Quek, Lake-Ee
van Geldermalsen, Michelle
Guan, Yi Fang
Wahi, Kanu
Mayoh, Chelsea http://orcid.org/0000-0002-6398-3046
Balaban, Seher
Pang, Angel
Wang, Qian
Cowley, Mark J. http://orcid.org/0000-0002-9519-5714
Brown, Kristin K.
Turner, Nigel
Hoy, Andrew J. http://orcid.org/0000-0003-3922-1137
Holst, Jeff http://orcid.org/0000-0002-0377-9318
Funding for this research was provided by:
National Breast Cancer Foundation (ECF-12-05)
Cancer Council NSW (RG18-06)
Cancer Institute NSW (2019/CDF009)
Article History
Received: 16 February 2022
Revised: 30 June 2022
Accepted: 1 July 2022
First Online: 18 July 2022
Competing interests
: JH was previously chief scientific officer of MetabloQ pharmaceuticals and received commercial research support and consultant fees for an unrelated project. The other authors declare no competing interests.